Clinical Studies

Call us!

Ashland: 541.488.3192

Grants Pass: 541.956.6471

Emergency: 911

Studies

  • ALLEGRO Sponsored by Allegro
    Evaluating the safety of investigational drug compared to Avastin in patients with DME
  • CLG561-2201 Sponsored by Alcon **Currently Enrolling**
    Evaluating the safety of investigational
    drug alone, or in combination with LFG316 in patients with geographic atrophy from dry AMD

  • CLG561-2201 Sponsored by Alcon
    Evaluating the safety and efficacy of investigational drug in patients with geographic atrophy from dry AMD
  • HAWK Sponsored by Alcon **Currently Enrolling**
    Comparing the efficacy and safety of an investigational drug vs. Aflibercept (Eylea) in treatment-naïve patients with wet AMD

  • SEQUOIA Sponsored by Allergan **Currently Enrolling**
    Comparing investigational drug with ranibizumab (Lucentis) in treatment-naïve patients with wet AMD

  • MAKO Sponsored by Ohr Pharmaceutical, Inc. **Currently Enrolling**
    Evaluating the safety and efficacy of investigational
    eye drops in treatment-naïve patients with wet AMD

  • ICONIC Sponsored by Iconic Therapeutics
    Evaluating the safety of investigational
    drug alone, or in combination with ranibizumab (Lucentis), or ranibizumab (Lucentis) alone, in patients with wet AMD

  • OPHTHOTECH Sponsored by Ophthotech
    Evaluating the safety and efficacy of investigational drug in combination with ranibizumab (Lucentis), compared to ranibizumab (Lucentis) alone, in patients with wet AMD

These are some of the clinical trials that Retina & Vitreous of Southern Oregon has participated in. Please check our current studies section for recent activity.

Dr. Gonzales and Staff

Login